Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Pharma
Neurocrine elevates BD chief to succeed founder and CEO
The paucity of commercial-stage neuroscience biotechs has made Neurocrine a regular name on M&A watch lists. Now, the firm has a new CEO.
Angus Liu
May 29, 2024 11:42am
Neurocrine joins in on Tardive Dyskinesia Awareness Week
May 6, 2024 10:52am
AZ's Alexion debuts short film highlighting NMOSD community
Apr 18, 2024 2:16pm
FDA expands AZ's Ultomiris to NMOSD after prior rejection
Mar 25, 2024 10:31am
FDA awards Biogen's ALS drug Qalsody an accelerated approval
Apr 25, 2023 2:28pm
Setback at Lundbeck: CGRP migraine drug Vyepti hits trial snag
Aug 18, 2022 12:01pm
